{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T14:46:45Z","timestamp":1781362005173,"version":"3.54.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/j.clbc.2022.10.002","type":"journal-article","created":{"date-parts":[[2022,10,8]],"date-time":"2022-10-08T01:54:27Z","timestamp":1665194067000},"page":"1-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Radiation-induced skin changes after breast or chest wall irradiation in patients with breast cancer and skin of color: a systematic review"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1068-9449","authenticated-orcid":false,"given":"Juhi M.","family":"Purswani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christy","family":"Nwankwo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prince","family":"Adotama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen A.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian W.","family":"Tattersall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naamit K.","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clbc.2022.10.002_bib0001","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.clon.2003.08.005","article-title":"Impact of radiation therapy on acute toxicity in breast conservation therapy for early breast cancer","volume":"16","author":"Back","year":"2004","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.clbc.2022.10.002_bib0002","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.prro.2020.09.002","article-title":"Development of an illustrated scale for acute radiation dermatitis in breast cancer patients","volume":"11","author":"Shumway","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0003","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1186\/1471-2407-10-508","article-title":"Predictive factors of radiation-induced skin toxicity in breast cancer patients","volume":"10","author":"Chen","year":"2010","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.10.002_bib0004","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1200\/JCO.2007.15.2488","article-title":"A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis","volume":"26","author":"Pignol","year":"2008","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.clbc.2022.10.002_bib0005","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jaad.2019.03.011","article-title":"Characterizing the effects of radiation dermatitis on quality of life: a prospective survey-based study","volume":"86","author":"Rzepecki","year":"2019","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0006","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ijrobp.2016.01.043","article-title":"Radiation therapy noncompliance and clinical outcomes in an urban academic cancer center","volume":"95","author":"Ohri","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"10.1016\/j.clbc.2022.10.002_bib0007","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.3390\/ijms19092668","article-title":"Clinical and biological characterization of skin pigmentation diversity and its consequences on UV impact","volume":"19","author":"Del Bino","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.clbc.2022.10.002_bib0008","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/S0140-6736(08)60348-7","article-title":"The UK Standardization of Breast Radiotherapy (START) Trial B of radiotherapy hypofractionation for treatment of early breast cancer: a randomized trial","volume":"371","author":"Group","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.clbc.2022.10.002_bib0009","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1470-2045(13)70386-3","article-title":"The UK Standardization of Breast Radiotherapy (START) trials of radiotherapy hypofractionation for treatment of early breast cancer: 10-year follow-up results of two randomized controlled trials","volume":"14","author":"Haviland","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0010","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1056\/NEJMoa0906260","article-title":"Long-term results of hypofractionated radiation therapy for breast cancer","volume":"362","author":"Whelan","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clbc.2022.10.002_bib0011","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamaoncol.2015.2666","article-title":"Acute and short-term toxic effects of conventionally fractionated vs. hypofractionated whole-breast irradiation: a randomized clinical trial","volume":"1","author":"Shaitelman","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0012","unstructured":"Oxford Centre for Evidence-Based Medicine. Oxford Centre for Evidence-Based Medicine: levels of evidence (2009). Available at: https:\/\/www.cebm.ox.ac.uk\/resources\/levels-of-evidence\/oxford-centre-for-evidence-based-medicine-levels-of-evidence-march-2009. Accessed 1\/1\/2022."},{"key":"10.1016\/j.clbc.2022.10.002_bib0013","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1158\/1055-9965.EPI-14-0263","article-title":"Inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in patients with breast cancer","volume":"23","author":"Rodriguez-Gil","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clbc.2022.10.002_bib0014","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/cam4.608","article-title":"Prospective evaluation of radiation-induced skin toxicity in a race\/ethnically diverse breast cancer population","volume":"5","author":"Wright","year":"2016","journal-title":"Cancer Med"},{"key":"10.1016\/j.clbc.2022.10.002_bib0015","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1200\/JCO.2017.77.1790","article-title":"Association between inflammatory biomarker C-reactive protein and radiotherapy-induced early adverse skin reactions in a multiracial\/ethnic breast cancer population","volume":"36","author":"Hu","year":"2018","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0016","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.ijrobp.2019.12.021","article-title":"Association between polymorphisms in DNA damage repair genes and radiation therapy-induced early adverse skin reactions in a breast cancer population: a polygenic risk score approach","volume":"106","author":"Lee","year":"2020","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.10.002_bib0017","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijrobp.2014.06.042","article-title":"Racial variations in radiation-induced skin toxicity severity: data from a prospective cohort receiving postmastectomy radiation","volume":"90","author":"Wright","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.10.002_bib0018","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1097\/00130404-200307000-00014","article-title":"Clinical outcome and cosmesis in African-American patients treated with conservative surgery and radiation therapy","volume":"9","author":"Tuamokumo","year":"2003","journal-title":"Cancer J"},{"key":"10.1016\/j.clbc.2022.10.002_bib0019","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1097\/01.COC.0000020589.75948.E7","article-title":"Patient characteristics and treatment factors affecting cosmesis following lumpectomy and breast irradiation","volume":"26","author":"Deutsch","year":"2003","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0020","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/0360-3016(94)00480-3","article-title":"Factors influencing cosmetic results after conservation therapy for breast cancer","volume":"31","author":"Taylor","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.10.002_bib0021","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1002\/cncr.25088","article-title":"Differences in disease presentation, management techniques, treatment outcome, and toxicities in African-American women with early stage breast cancer treated with breast-conserving therapy","volume":"116","author":"Vicini","year":"2010","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2022.10.002_bib0022","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.prro.2021.08.004","article-title":"Predictors of acute radiation dermatitis and esophagitis in African American patients receiving whole-breast radiation therapy","volume":"12","author":"Dzul","year":"2022","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0023","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/sj.bjc.6603842","article-title":"Post-treatment skin reactions reported by cancer patients differ by race, not by treatment or expectations","volume":"97","author":"Ryan","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.clbc.2022.10.002_bib0024","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1002\/cncr.30547","article-title":"Treatment-associated toxicities reported by patients with early-stage invasive breast cancer","volume":"123","author":"Friese","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.clbc.2022.10.002_bib0025","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ijrobp.2011.08.013","article-title":"Cosmetic outcomes and complications reported by patients having undergone breast-conserving treatment","volume":"83","author":"Hill-Kayser","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.10.002_bib0026","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/pon.1734","article-title":"A qualitative analysis of acute skin toxicity among breast cancer radiotherapy patients","volume":"20","author":"Schnur","year":"2011","journal-title":"Psychooncology"},{"issue":"2","key":"10.1016\/j.clbc.2022.10.002_bib0027","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.ijrobp.2022.05.041","article-title":"A Comparison of Patient- and Clinician-Reported Acute Toxic Effects During Radiation Therapy for Primary Breast Cancer","volume":"114","author":"Lapen","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.10.002_bib0028","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12885-021-08047-5","article-title":"Radiation-irritated skin and hyperpigmentation may impact the quality of life of breast cancer patients after whole breast radiotherapy","volume":"21","author":"Chu","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.clbc.2022.10.002_bib0029","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2325\/jbcs.13.197","article-title":"Results of a questionnaire survey for symptom of late complications caused by radiotherapy in breast conserving therapy","volume":"13","author":"Ishiyama","year":"2006","journal-title":"Breast Cancer"},{"key":"10.1016\/j.clbc.2022.10.002_bib0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.ctim.2019.102205","article-title":"Nigella sativa L. for prevention of acute radiation dermatitis in breast cancer: A randomized, double-blind, placebo-controlled, clinical trial","volume":"47","author":"Rafati","year":"2019","journal-title":"Complement Ther Med"},{"key":"10.1016\/j.clbc.2022.10.002_bib0031","first-page":"9","article-title":"Late cutaneous effects of a local potent steroid during adjuvant radiotherapy for breast cancer","volume":"7","author":"Ulff","year":"2017","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0032","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.radonc.2015.08.028","article-title":"Hydrosorb(R) versus control (water based spray) in the management of radio-induced skin toxicity: Results of multicenter controlled randomized trial","volume":"117","author":"Bazire","year":"2015","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0033","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.radonc.2020.02.018","article-title":"Acute radiation-induced skin toxicity in hypofractionated vs. conventional whole-breast irradiation: An objective, randomized multicenter assessment using spectrophotometry","volume":"146","author":"Schmeel","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0034","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1001\/archderm.1988.01670060015008","article-title":"The validity and practicality of sun-reactive skin types I through VI","volume":"124","author":"Fitzpatrick","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0035","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1007\/s00066-010-2134-1","article-title":"Objective assessment of dermatitis following post-operative radiotherapy in patients with breast cancer treated with breast-conserving treatment","volume":"186","author":"Yoshida","year":"2010","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0036","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s11604-012-0073-8","article-title":"Assessment of radiation dermatitis using objective analysis for patients with breast cancer treated with breast-conserving therapy: influence of body weight","volume":"30","author":"Yamazaki","year":"2012","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0037","article-title":"Quantitative evaluation of radiodermatitis following whole-breast radiotherapy with various color space models: A feasibility study","volume":"17","author":"Park","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2022.10.002_bib0038","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s11604-009-0345-0","article-title":"Longitudinal practical measurement of skin color and moisture during and after breast-conserving therapy: influence of neoadjuvant systemic therapy","volume":"27","author":"Yamazaki","year":"2009","journal-title":"Jpn J Radiol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0039","doi-asserted-by":"crossref","first-page":"12306","DOI":"10.1038\/s41598-018-30710-4","article-title":"Comparison of radiation dermatitis between hypofractionated and conventionally fractionated postoperative radiotherapy: objective, longitudinal assessment of skin color","volume":"8","author":"Yamazaki","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.clbc.2022.10.002_bib0040","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.ijrobp.2010.07.035","volume":"81","author":"Tanaka","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.10.002_bib0041","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0218018","article-title":"Testing the feasibility of augmented digital skin imaging to objectively compare the efficacy of topical treatments for radiodermatitis","volume":"14","author":"Partl","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/j.clbc.2022.10.002_bib0042","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0167-8140(94)90460-X","article-title":"Quantification of patient to patient variation of skin erythema developing as a response to radiotherapy","volume":"30","author":"Russell","year":"1994","journal-title":"Radiother Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2022.10.002_bib0043","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.3390\/cancers12092444","article-title":"Objective Evaluation of Risk Factors for Radiation Dermatitis in Whole-Breast Irradiation Using the Spectrophotometric L*a*b Color-Space","volume":"12","author":"Bohner","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clbc.2022.10.002_bib0044","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1007\/s00066-005-1345-3","article-title":"Spectrophotometric skin measurements correlate with EORTC\/RTOG-common toxicity criteria","volume":"181","author":"Momm","year":"2005","journal-title":"Strahlenther Onkol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0045","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1080\/02841860701243087","article-title":"Comparison of three instrumental methods for the objective evaluation of radiotherapy induced erythema in breast cancer patients and a study of the effect of skin lotions","volume":"46","author":"Nystrom","year":"2007","journal-title":"Acta Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2022.10.002_bib0046","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1016\/j.clbc.2021.06.013","article-title":"Quantitative Changes in Skin Composition Parameters after Radiation Therapy According to Surgery Types Among Patients with Breast Cancer: A Prospective Study","volume":"22","author":"Yoo","year":"2021","journal-title":"Clin Breast Cancer"},{"key":"10.1016\/j.clbc.2022.10.002_bib0047","first-page":"466","article-title":"Top dermatologic conditions in patients of color: an analysis of nationally representative data","volume":"11","author":"Davis","year":"2012","journal-title":"J Drugs Dermatol"},{"issue":"2","key":"10.1016\/j.clbc.2022.10.002_bib0048","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1067\/mjd.2002.120790","article-title":"Skin of color: biology, structure, function, and implications for dermatologic disease","volume":"46","author":"Taylor","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0049","first-page":"452","article-title":"The Roberts Skin Type Classification System","volume":"7","author":"Roberts","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0050","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/srt.12680","article-title":"Evaluation of different factors influencing objective measurement of skin color by colorimetry","volume":"25","author":"Anbar","year":"2019","journal-title":"Skin Res Technol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0051","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jid.2019.11.003","article-title":"Research techniques made simple: cutaneous colorimetry: a reliable technique for objective skin color measurement","volume":"140","author":"Ly","year":"2020","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0052","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1001\/jamadermatol.2015.0351","article-title":"Fitzpatrick skin type, individual typology angle, and melanin index in an african population: steps toward universally applicable skin photosensitivity assessments","volume":"151","author":"Wilkes","year":"2015","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0053","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1001\/jamaoncol.2015.2590","article-title":"Differences in the acute toxic effects of breast radiotherapy by fractionation schedule: comparative analysis of physician-assessed and patient-reported outcomes in a large multicenter cohort","volume":"1","author":"Jagsi","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0054","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.radonc.2012.03.019","article-title":"Phase II trial of 3D-conformal accelerated partial breast irradiation: lessons learned from patients and physicians' evaluation","volume":"103","author":"Azoury","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0055","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.12968\/bjon.1999.8.19.1305","article-title":"Radiation-induced skin reactions. 3: Evaluating the RISRAS","volume":"8","author":"Noble-Adams","year":"1999","journal-title":"Br J Nurs"},{"key":"10.1016\/j.clbc.2022.10.002_bib0056","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/1523-1747.ep12365600","article-title":"Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness","volume":"107","author":"Chren","year":"1996","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0057","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/01.coc.0000138965.97476.0f","article-title":"Preliminary reliability and validity testing of a new Skin Toxicity Assessment Tool (STAT) in breast cancer patients undergoing radiotherapy","volume":"27","author":"Berthelet","year":"2004","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0058","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.ijrobp.2021.11.026","article-title":"Delivery of Adjuvant Radiation in 5 Days or Less After Lumpectomy for Breast Cancer: A Systematic Review","volume":"112","author":"Vicini","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clbc.2022.10.002_bib0059","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2016.02.027","article-title":"Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward Trial","volume":"120","author":"Brunt","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clbc.2022.10.002_bib0060","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/j.ijrobp.2021.07.1692","article-title":"Development and pilot implementation of a remote monitoring system for acute toxicity using electronic patient-reported outcomes for patients undergoing radiation therapy for breast cancer","volume":"111","author":"Lapen","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922002257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820922002257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,28]],"date-time":"2025-05-28T21:18:19Z","timestamp":1748467099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820922002257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S1526820922002257"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2022.10.002","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Radiation-induced skin changes after breast or chest wall irradiation in patients with breast cancer and skin of color: a systematic review","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2022.10.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}